Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

USA: Researchers have found in a new study that patients with idiopathic intracranial hypertension (IIH) treated with ...

Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

In this cooking video, discover how to make a delicious and comforting oxtail dish using a slow cooking technique. The recipe ...

PYPD PolyPid Ltd. (NASDAQ:PYPD) is a late clinical stage biopharma company focused on developing locally administered, prolonged-release therapeutics using its proprietary Polymer-Lipid Encapsulation ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all.

PolyPid's proprietary and clinically validated, prolonged-release drug delivery technology aims to subcutaneously deliver GLP-1 for approximately 60 days, ...

Roughly 16 million American adults are taking GLP-1 medications. They are a major breakthrough for people to shed pounds and manage conditions such as Type 2 diabetes. However, doctors say there’s a ...

The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...